IS8188A - Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogæxlisdrepboða a - Google Patents

Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogæxlisdrepboða a

Info

Publication number
IS8188A
IS8188A IS8188A IS8188A IS8188A IS 8188 A IS8188 A IS 8188A IS 8188 A IS8188 A IS 8188A IS 8188 A IS8188 A IS 8188A IS 8188 A IS8188 A IS 8188A
Authority
IS
Iceland
Prior art keywords
antagonist
pharmaceutical preparation
tumor
receptor
receptor antagonist
Prior art date
Application number
IS8188A
Other languages
English (en)
Inventor
Boughton-Smith Nigel
Original Assignee
Astra Zeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0312321A external-priority patent/GB0312321D0/en
Priority claimed from SE0301655A external-priority patent/SE0301655D0/xx
Application filed by Astra Zeneca Ab filed Critical Astra Zeneca Ab
Publication of IS8188A publication Critical patent/IS8188A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS8188A 2003-05-29 2005-12-20 Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogæxlisdrepboða a IS8188A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0312321A GB0312321D0 (en) 2003-05-29 2003-05-29 New combination
SE0301655A SE0301655D0 (sv) 2003-06-05 2003-06-05 New combination
PCT/SE2004/000817 WO2004105798A1 (en) 2003-05-29 2004-05-27 A PHARMACEUTICAL COMPOSITION COMPRISING A P2X7-RECEPTOR ANTAGONIST AND A TUMOUR NECROSIS FACTOR α

Publications (1)

Publication Number Publication Date
IS8188A true IS8188A (is) 2005-12-20

Family

ID=33492248

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8188A IS8188A (is) 2003-05-29 2005-12-20 Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogæxlisdrepboða a

Country Status (15)

Country Link
US (1) US20070032465A1 (is)
EP (1) EP1633401A1 (is)
JP (1) JP2007501270A (is)
KR (1) KR20060037258A (is)
AR (1) AR044452A1 (is)
BR (1) BRPI0410739A (is)
CA (1) CA2526883A1 (is)
CO (1) CO5640094A2 (is)
IS (1) IS8188A (is)
MX (1) MXPA05012705A (is)
NO (1) NO20056131L (is)
RU (1) RU2350354C2 (is)
TW (1) TW200507829A (is)
UY (1) UY28335A1 (is)
WO (1) WO2004105798A1 (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200920D0 (sv) * 2002-03-25 2002-03-25 Astrazeneca Ab Novel compounds
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
US20070010497A1 (en) * 2003-05-29 2007-01-11 Nigel Boughton-Smith Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
WO2004105796A1 (en) * 2003-05-29 2004-12-09 Astrazeneca Ab A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate
SE0302192D0 (sv) * 2003-08-08 2003-08-08 Astrazeneca Ab Novel compounds
SE0302488D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab New combination
SA05260265A (ar) * 2004-08-30 2005-12-03 استرازينيكا ايه بي مركبات جديدة
SE0402925D0 (sv) * 2004-11-30 2004-11-30 Astrazeneca Ab Novel Compounds
JP5134530B2 (ja) * 2005-03-07 2013-01-30 ライラ ニュートラシューティカルズ ボスウェル酸及び選択的に濃縮したボスウェル酸の新規な塩、ならびにそのための方法
GB0919594D0 (en) 2009-11-09 2009-12-23 Glaxo Group Ltd Compounds
CA2792258A1 (en) 2010-03-05 2011-09-09 President And Fellows Of Harvard College Induced dendritic cell compositions and uses thereof
US9538710B2 (en) 2010-04-01 2017-01-10 Tony Wayne Covely Crop product tracking system and method
US10444122B2 (en) 2010-04-01 2019-10-15 Agri-Labs Holdings Llc Soil sample tracking system and method
CN103841969A (zh) * 2011-08-04 2014-06-04 美国卫生和人力服务部 经由药物介导的对类二十烷酸平衡的操作治疗和预防微生物介导的疾病
AU2013262611B2 (en) 2012-05-18 2018-03-01 Genentech, Inc. High-concentration monoclonal antibody formulations
KR102035463B1 (ko) * 2018-02-14 2019-11-26 연세대학교 산학협력단 암 줄기세포의 치료용 약학 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3471491A (en) * 1967-08-28 1969-10-07 Squibb & Sons Inc Adamantyl-s-triazines
US3464998A (en) * 1968-03-04 1969-09-02 Searle & Co Adamantyl esters and amides of pyridinecarboxylic acids
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
US4751292A (en) * 1985-07-02 1988-06-14 The Plant Cell Research Institute, Inc. Adamantyl purines
US5399564A (en) * 1991-09-03 1995-03-21 Dowelanco N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
TR199802385T2 (xx) * 1996-05-20 1999-04-21 Darwin Discovery Limited TNF inhibit�rleri ve FDE-IV inhibit�rleri olarak kinolin karboksamidler.
SE9704544D0 (sv) * 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
SE9704545D0 (sv) * 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
CZ20013608A3 (cs) * 1999-04-09 2002-05-15 Astrazeneca Ab Adamantanové deriváty
SE9904505D0 (sv) * 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) * 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
GB0013737D0 (en) * 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
HUP0400390A2 (hu) * 2001-07-02 2004-09-28 Akzo Nobel N.V. Tetrahidrokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények
WO2003042190A1 (en) * 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8557501A1 (es) * 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
US6908939B2 (en) * 2001-12-21 2005-06-21 Galderma Research & Development S.N.C. Biaromatic ligand activators of PPARγ receptors
SE0200920D0 (sv) * 2002-03-25 2002-03-25 Astrazeneca Ab Novel compounds
SE0300445D0 (sv) * 2003-02-18 2003-02-18 Astrazeneca Ab New combination
SE0300480D0 (sv) * 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
WO2004105796A1 (en) * 2003-05-29 2004-12-09 Astrazeneca Ab A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate
US20070010497A1 (en) * 2003-05-29 2007-01-11 Nigel Boughton-Smith Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
SE0302192D0 (sv) * 2003-08-08 2003-08-08 Astrazeneca Ab Novel compounds
SE0302488D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab New combination

Also Published As

Publication number Publication date
WO2004105798A1 (en) 2004-12-09
US20070032465A1 (en) 2007-02-08
BRPI0410739A (pt) 2006-06-27
JP2007501270A (ja) 2007-01-25
RU2350354C2 (ru) 2009-03-27
CO5640094A2 (es) 2006-05-31
NO20056131L (no) 2006-02-28
TW200507829A (en) 2005-03-01
EP1633401A1 (en) 2006-03-15
CA2526883A1 (en) 2004-12-09
KR20060037258A (ko) 2006-05-03
MXPA05012705A (es) 2006-02-08
RU2005136131A (ru) 2006-07-27
UY28335A1 (es) 2004-12-31
AR044452A1 (es) 2005-09-14
AU2004243137A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
IS8188A (is) Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogæxlisdrepboða a
LUC00127I1 (fr) Dacomitinib et ses derives pharmaceutiquement accepatbles ( vizimpro )
IS2946B (is) Lyfjablanda sem felur í sér andrógen
FI7846U1 (fi) Farmaseuttinen valmiste, joka sisältää oksikodonia ja naloksonia
NO20042905L (no) Farmasoytisk nanopartikkelpreparat av en takykinin reseptor antagonist
EP1515674A4 (en) AGAINST MISUSE PROTECTED SOLID OPIOID DOSAGE FORM
TWI349664B (en) Benzimidazole derivatives: preparation and pharmaceutical applications
IS8353A (is) Lyfjablanda sem felur í sér lantanefnasambönd
IS8190A (is) Ný P2X7 viðtakamótlyf og notkun þeirra
IL171285A (en) Pharmaceuticals containing interleukin-6 antagonist and their uses
EP1653960A4 (en) MELANIN CONCENTRATION HORMONE RECEPTOR ANTAGONIST
ZA200506240B (en) Coated particles and pharmaceutical dosage forms
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
DE60308372D1 (de) Dosierungsverabreichungsvorrichtung
IS7491A (is) Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
EP1812079A4 (en) EVALUATION OF PHARMACEUTICAL MIXTURES
IS8396A (is) Lyfjablanda sem felur í sér P2X7 viðtakamótlyf ogbólgueyðandi lyf án stera
IL169575A0 (en) Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same
IL184158A0 (en) Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
ATE446091T1 (de) Basische nichtpeptid-bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus
DK1808446T3 (da) IL-18-receptor-antagonist og farmaceutisk sammensætning indeholdende antagonisten
IL178067A0 (en) Pharmaceutical dosage forms and compositions
PL1673349T3 (pl) Pochodne benzimidazolu: wytwarzanie i zastosowania farmaceutyczne
NO20033162L (no) Farmasöytisk tablett omfattende paroksetinmesylat